fangchinoline has been researched along with Benign Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Check Hayden, E | 1 |
Ahn, KS; Arfuso, F; Fan, L; Mérarchi, M; Mishra, S; Sethi, G | 1 |
1 review(s) available for fangchinoline and Benign Neoplasms
Article | Year |
---|---|
Molecular Targets Modulated by Fangchinoline in Tumor Cells and Preclinical Models.
Topics: Alkaloids; Apoptosis; Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Humans; Molecular Targeted Therapy; Neoplasms; Stephania tetrandra | 2018 |
1 other study(ies) available for fangchinoline and Benign Neoplasms
Article | Year |
---|---|
The rise and fall and rise again of 23andMe.
Topics: Antibodies, Monoclonal; Benzylisoquinolines; Biosensing Techniques; Bloom Syndrome; Cardiovascular Diseases; Disclosure; Drug Discovery; False Positive Reactions; Gaucher Disease; Genes, BRCA1; Genes, BRCA2; Genetic Predisposition to Disease; Genetic Testing; Genome-Wide Association Study; Heredity; Humans; Iceland; Immune System Diseases; Information Dissemination; Neoplasms; Parkinson Disease; Pharmacogenetics; Predictive Value of Tests; Reproducibility of Results; Self Report; Skin Diseases; Translational Research, Biomedical; United States; United States Food and Drug Administration | 2017 |